A Multi-center Randomized Clinical Trial About Using LMA or ETI in Elderly Patients

Not Applicable

Completed

• Conditions: Complications; Surgery
• Interventions: Device: Laryngeal mask airway（LMA）; Device: Endotracheal intubation（ETI）

• Registration Number: NCT02240901
• Lead Sponsor: RenJi Hospital

Brief Summary

Perioperative airway management is a top priority of anesthesiologists in daily work, and endotracheal intubation (ETI) is considered as the gold standard for providing safe glottic seal,effective ventilation and oxygen supplement during general anesthesia. But ETI related complications such as concomitant hemodynamic responses, damage to the oropharyngeal structures at insertion and postoperative sore throat. Laryngeal mask airway(LMA) for the anesthesia management brings new choice with invasive, lighter cardiovascular reaction and many other advantages, particularly suited to short and minimally invasive surgery. But LMA increased the risk of gastrointestinal reflux aspiration than using ETI and it may resulted in intolerance in high airway pressure, especially in elderly patients with increased lung compliance or reduced airway resistance. Furthermore, LMA could not entirely prevent the occurrence of postoperative sore throat and hoarse.

To sum up, it is necessary to carry out a multicenter clinical trial to clarify the safety of LMA in elderly patients. The investigators protocol will focus on the incidence of postoperative pulmonary complications (PPCs) when applications of LMA and ETI in elderly patients.

Detailed Description

1. Introduction 1.1 Background It is essential for peri-operative patients to ensure airway patency and effective ventilation, and respiratory is the most important task in anesthesiologist's daily work. Endotracheal intubation(ETI) is the gold standard for maintenance patients' ventilation in general anesthesia. It can effectively send narcotic gas into the trachea and allow oxygen ventilation well controlled. However, ETI-related complications such as dental and oral soft tissue injury, intubation and extubation related cardiovascular reactions, hinder its application in some special populations such as elderly patients. Clinical application of laryngeal mask airway (LMA) has brought new options and new ideas for anesthesia management. LMA has the advantage of light damage, small trauma, simple operation and minor cardiovascular response, and it is especially suitable for airway control of patient in short and minimally invasive operation. In recent years, the application of LMA has a greater proportion compared with ETI in some areas. But with LMA application increasing, more and more problems have been reported.

LMA has a greater risk of gastrointestinal reflux and aspiration, because of its inadequate airway tightness. For the same reason, LMA is of intolerance to high airway pressure, and this may lead to hypoventilation in elderly patients with lung compliance or increased airway resistance. At the same time the LMA can't completely prevent incidence of postoperative sore throat and hoarseness. Therefore, it is necessary to carry out a multi-center clinical trial to clarify the peri-operative advantages and disadvantages of LMA to elderly patients, to preliminary explore the LMA complications occurred in elderly patients using predictive models, and to clarify the safety of the LMA in airway support of elderly patients.

1.2 Research Aims The aim of the present research is to study the effects of LMA compared with conventional ETI on elderly patients considering postoperative pulmonary complications, anesthesia and recovery quality, oxygenation and airway support related complications.

1.3 Primary endpoint events Postoperative pulmonary complications before discharge. 1.4 Secondary endpoint events and other pre-specified outcomes 1.4.1 Mortality 1.4.2 PACU stay 1.4.3 Hospiitalization cost and duration 1.4.4 ICU admission and stay time (patients who meet the ICU inclusion criteria are admitted into ICU, those who are admitted into ICU because of bed conversion are excluded, and those who should have been out of ICU are also excluded) 1.4.5 Treatment for PPCs 1.4.6 Blood and sputum culture

Study Timeline

• Study First Submitted: 2014-08-23
• Study First Submitted QC: 2014-09-15
• Study First Posted: 2014-09-16
• Study Start: 2016-08-03
• Primary Completion: 2020-01-23
• Study Completion: 2020-04-15
• Status Verified: 2020-10
• Last Update Submitted: 2020-10-26
• Last Update Posted: 2020-10-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2900

Inclusion Criteria

• Age ≥ 70
• Elective surgery
• BMI ≤ 35 kg/m2
• Provision of signed informed consent

Exclusion Criteria

• emergency surgery
• have anticipated difficult intubation
• have a broken or unstable cervix
• have laryngeal disease
• are at high risk of aspiration (gastroesophageal reflux disease, full stomach)
• are unable to cooperate for any reason, such as inability to speak or understand, mental disease, or inability to go to the clinics
• have taken experimental drugs in the preceding 3 months or joined another clinical trial
• did not provide informed consent or have withdrawn consent
• are evaluated by the investigator as unsuitable for this trial

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Laryngeal mask airway	Laryngeal mask airway（LMA）	Laryngeal mask airway（LMA） is used to maintain mechanical ventilation during intra-operative
Endotracheal intubation group（ETI）	Endotracheal intubation（ETI）	Endotracheal intubation group（ETI）is used to maintain mechanical ventilation during intra-operative

Primary Outcome Measures

Name	Time	Method
The occurrence of postoperative pulmonary complications	before discharge	five-category scale to assess the pulmonary outcomes: 0, no pulmonary complications 1, either one of the following: cough, minor lung atelectasis, dyspnea; 2, cough and sputum, bronchospasm, hypoxemia, atelectasis, hypercapnia; 3, pleural effusion, suspected pneumonia, diagnosed pneumonia, pneumothorax, diagnosed pneumonia, pneumothorax, non-invasive or invasive mechanical ventilation\<48hr 4, respiratory failure.

Secondary Outcome Measures

Name	Time	Method
mortality	before discharge
ICU admission rate	before discharge	Patients who meet the ICU inclusion criteria are admitted into ICU, those who are admitted into ICU because of bed conversion are excluded, and those who should have been out of ICU are also excluded
Hospitalization days	before discharge
PACU stay	before discharge	PACU stay time collection is based on anesthesia records
Blood and sputum culture	before discharge	In-hospital medical examinations and tests will be collected
Treatment for PPCs	before discharge	Included antibiotics, anti-sputum drugs, steroids, mechanical ventilation
ICU stay	before discharge	Patients who meet the ICU inclusion criteria are admitted into ICU, those who are admitted into ICU because of bed conversion are excluded, and those who should have been out of ICU are also excluded
Hospiitalization cost	before discharge	Hospitalization cost is collected from hospital bill, regardless of patient's insurerance coverage

Trial Locations

Locations (1)

Renji Hospital, Shanghai Jiaotong University School of Medicine; 🇨🇳 Shanghai, China